Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vu Truong Insider Profile
4 Followers
Vu Truong, CEO, Director at Aridis Pharmaceuticals, holds 1.38M shares in Aridis Pharmaceuticals (Ticker: ARDS). Most recently, Vu Truong Bought $714,286 shares of Aridis Pharmaceuticals on Jun 28, 2024 for an estimated value of 50.00K.
Vu Truong Aridis Pharmaceuticals (ARDS)CEO, Director
Aridis Pharmaceuticals (ARDS)
CEO, Director
Not Ranked
Ranked #44,262 out of 100,202 Corporate Insiders
Vu Truong has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Vu Truong holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 27, 2021 - Jul 27, 2022
Return:-71.40%
The most profitable trade made by Vu Truong
Vu Truong's Trading History
List of latest transactions for each holding click on a transaction to see Vu Truong's performance on stock
You May Also Like
Vu Truong insider profile FAQ
What is the percentage of profitable transactions made by Vu Truong?
The percentage of profitable transactions made by Vu Truong is ―.
What is the average return per transaction made by Vu Truong?
The average return per transaction made by Vu Truong is ―.
What stocks does Vu Truong hold?
Vu Truong holds: ARDS stocks.
What was Vu Truong’s latest transaction?
Vu Truong latest transaction was an Informative Buy of $50.00K.
What was Vu Truong's most profitable transaction?
Vu Truong’s most profitable transaction was an Informative Buy of ARDS stock on July 27, 2021. The return on the trade was -71.40%.
What is Vu Truong's role in Aridis Pharmaceuticals?
Vu Truong's role in Aridis Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.